{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:53:17Z","timestamp":1789750397486,"version":"4.0.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>A recently discovered facet of paraneoplastic adrenocorticotropic hormone (ACTH) deficiency exists in two forms: a paraneoplastic spontaneous isolated ACTH deficiency (IAD) and an immune checkpoint inhibitor (ICI)-related hypophysitis. Autoantibodies against corticotrophs, such as circulating anti-proopiomelanocortin (POMC) antibodies are considered disease markers. However, the number of identified cases was limited, implying that the characteristics of these autoantibodies are not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigate circulating autoimmune autoantibodies in detail through a novel case of IAD that developed as a paraneoplastic autoimmune ACTH deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patient developed IAD after 25 weeks of ICI therapy for metastasis of large-cell neuroendocrine carcinoma at 69 years of age. Ectopic ACTH expression and infiltration of CD3+, CD4+, CD8+, and CD20+ lymphocytes were observed in the tumor tissues and circulating anti-POMC antibodies were detected specifically in the patient\u2019s serum. Moreover, detailed analyses of immunofluorescence staining using patient serum revealed that the recognition site of the autoantibody was ACTH\n                      <jats:sub>25-39<\/jats:sub>\n                      , which had not been identified in previous cases of paraneoplastic autoimmune ACTH deficiency.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case involved a combination of paraneoplastic spontaneously acquired IAD and ICI-related hypophysitis occupying the middle ground. Moreover, our study reveals new aspects of anti-POMC antibodies in patients with paraneoplastic ACTH deficiency. This report expands our understanding of the immunological landscape and provides new insights for the identification of antibodies associated with paraneoplastic autoimmune ACTH deficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1284301","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T08:17:09Z","timestamp":1699949829000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody"],"prefix":"10.3389","volume":"14","author":[{"given":"Shin","family":"Urai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Tachihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgab672","article-title":"Hypophysitis, the growing spectrum of a rare pituitary disease","volume":"107","author":"Langlois","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00437-2","article-title":"Insights into non-classic and emerging causes of hypopituitarism","volume":"17","author":"Prodam","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-006-0408-5","article-title":"Isolated corticotrophin deficiency","volume":"9","author":"Andrioli","year":"2006","journal-title":"Pituitary"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0164-9","article-title":"Isolated acquired ACTH deficiency and primary hypothyroidism: a short series and review","volume":"14","author":"Hannon","year":"2011","journal-title":"Pituitary"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102454","article-title":"Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors","volume":"19","author":"Percik","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01141-8","article-title":"Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review","volume":"24","author":"Iglesias","year":"2021","journal-title":"Pituitary"},{"key":"B7","article-title":"Heterogeneity of anterior pituitary cell antibodies detected in insulin-dependent diabetes mellitus and adrenocorticotropic hormone deficiency","volume":"3","author":"Sugiura","year":"1986","journal-title":"Diabetes Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-5-1391","article-title":"Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides","volume":"70","author":"Sauter","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.578802","article-title":"Clinical heterogeneity of acquired idiopathic isolated adrenocorticotropic hormone deficiency","volume":"12","author":"Fujita","year":"2021","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101663","article-title":"The novel concept of \u201cOnco-Immuno-Endocrinology\u201d led to the discovery of new clinical entity \u201cparaneoplastic autoimmune hypophysitis\u201d","volume":"36","author":"Takahashi","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0901-7","article-title":"Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome","volume":"21","author":"Bando","year":"2018","journal-title":"Pituitary"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02955-y","article-title":"Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome","volume":"70","author":"Kanie","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101601","article-title":"Paraneoplastic autoimmune hypophysitis: An emerging concept","volume":"36","author":"Bando","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej12-0110","article-title":"Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method","volume":"59","author":"Isojima","year":"2012","journal-title":"Endocr J"},{"key":"B18","unstructured":"Common terminology criteria for adverse events. Version 5.02020"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01231-1","article-title":"HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency","volume":"25","author":"Ono","year":"2022","journal-title":"Pituitary"},{"key":"B20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejca.2020.02.049","article-title":"Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor-induced secondary adrenal insufficiency","volume":"130","author":"Yano","year":"2020","journal-title":"Eur J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002493","article-title":"Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors","volume":"9","author":"Kobayashi","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2702","article-title":"HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis","volume":"100","author":"Heaney","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01407-9","article-title":"Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists","volume":"125","author":"Lindsay","year":"2021","journal-title":"Br J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02768-0","article-title":"Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort","volume":"74","author":"Toivanen","year":"2021","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ23-0050","article-title":"Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome","volume":"70","author":"Takahashi","year":"2023","journal-title":"Endocr J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2784-1","article-title":"Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer","volume":"36","author":"Hao","year":"2015","journal-title":"Tumour Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02077","article-title":"RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome","volume":"154","author":"Messager","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2017","article-title":"POMC: the physiological power of hormone processing","volume":"98","author":"Harno","year":"2018","journal-title":"Physiol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz003","article-title":"Autoimmune pituitary disease: new concepts with clinical implications","volume":"41","author":"Yamamoto","year":"2020","journal-title":"Endocr Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/eje.0.1490079","article-title":"Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions","volume":"149","author":"Raffin-Sanson","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-25-10-1361","article-title":"Immunologic studies of adrenocorticotropic hormone (ACTH): dissociation of biologic and immunologic activities","volume":"25","author":"Imura","year":"1965","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0436","article-title":"Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands","volume":"67","author":"Iwama","year":"2020","journal-title":"Endocr J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0551","article-title":"Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up","volume":"95","author":"Bellastella","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0526-9","article-title":"Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism","volume":"17","author":"De Bellis","year":"2014","journal-title":"Pituitary"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac161","article-title":"Endocrine autoantibodies determine immune checkpoint inhibitor-induced endocrinopathy: A prospective study","volume":"107","author":"Labadzhyan","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1284301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T08:17:12Z","timestamp":1699949832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1284301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2023.1284301"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1284301","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"article-number":"1284301"}}